Pharmaniaga Berhad (KLSE: PHARMA)
Malaysia
· Delayed Price · Currency is MYR 0.360
-0.005 (-1.37%)
At close: Nov 13, 2024
Pharmaniaga Berhad Cash Flow Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -56.33 | -80.16 | -629.92 | 172.15 | 27.49 | -149.22 | Upgrade
|
| Depreciation & Amortization | 37.49 | 38.77 | 34.02 | 31.7 | 30.76 | 34.74 | Upgrade
|
| Other Amortization | 5.38 | 2.93 | 2.41 | 1.68 | 1.58 | 1.53 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 247.32 | Upgrade
|
| Other Operating Activities | -46.46 | 85.41 | 451.15 | -269.58 | -85.54 | 55.39 | Upgrade
|
| Operating Cash Flow | -59.91 | 46.95 | -142.34 | -64.06 | -25.71 | 189.77 | Upgrade
|
| Capital Expenditures | -50.9 | -50.67 | -59.26 | -30.39 | -9.25 | -20.38 | Upgrade
|
| Sale of Property, Plant & Equipment | -3.49 | 1.32 | 0.06 | 0.21 | 0 | 0.07 | Upgrade
|
| Sale (Purchase) of Intangibles | -10.34 | -10.34 | -18.38 | -14.97 | -23.38 | -52.37 | Upgrade
|
| Other Investing Activities | -8.24 | -8.24 | 5.25 | -0.41 | - | -0.01 | Upgrade
|
| Investing Cash Flow | -79.48 | -67.93 | -72.34 | -45.56 | -32.64 | -72.68 | Upgrade
|
| Short-Term Debt Issued | - | 50 | - | - | - | 1,431 | Upgrade
|
| Long-Term Debt Issued | - | 3,248 | 2,291 | 2,329 | 1,541 | - | Upgrade
|
| Total Debt Issued | 3,322 | 3,298 | 2,291 | 2,329 | 1,541 | 1,431 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -1,512 | Upgrade
|
| Long-Term Debt Repaid | - | -3,240 | -1,988 | -2,149 | -1,443 | -3.82 | Upgrade
|
| Total Debt Repaid | -3,195 | -3,240 | -1,988 | -2,149 | -1,443 | -1,516 | Upgrade
|
| Net Debt Issued (Repaid) | 127.08 | 57.48 | 303.42 | 179.73 | 97.72 | -84.62 | Upgrade
|
| Issuance of Common Stock | 45.86 | 45.86 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -0.03 | -7.86 | -82.53 | -58.95 | -26.14 | -40.4 | Upgrade
|
| Other Financing Activities | -0.2 | -0.21 | -0.1 | -0.04 | -0.09 | -0.26 | Upgrade
|
| Financing Cash Flow | 172.71 | 95.27 | 220.79 | 120.74 | 71.49 | -125.28 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.83 | 0.31 | -0.39 | 0.13 | -0.23 | 0.32 | Upgrade
|
| Net Cash Flow | 32.5 | 74.59 | 5.74 | 11.25 | 12.91 | -7.88 | Upgrade
|
| Free Cash Flow | -110.81 | -3.72 | -201.6 | -94.44 | -34.96 | 169.39 | Upgrade
|
| Free Cash Flow Margin | -3.19% | -0.11% | -5.79% | -1.96% | -1.28% | 6.01% | Upgrade
|
| Free Cash Flow Per Share | -0.08 | -0.00 | -0.15 | -0.07 | -0.03 | 0.13 | Upgrade
|
| Cash Interest Paid | 71.74 | 60.81 | 41.29 | 32.63 | 38.57 | 38.04 | Upgrade
|
| Cash Income Tax Paid | 22.33 | 20.56 | 39.52 | 39.7 | 2.94 | 10.34 | Upgrade
|
| Levered Free Cash Flow | 109.57 | 31.75 | 479.12 | -143.76 | -75.73 | 88.29 | Upgrade
|
| Unlevered Free Cash Flow | 152.11 | 70.4 | 504.15 | -122.93 | -54.67 | 113.45 | Upgrade
|
| Change in Net Working Capital | -163.18 | -102.48 | -525.76 | 304.8 | 97.56 | -88.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.